This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
F-18 fluoroestradiol (FES)-PETscans can predict whether or not endocrine therapy may be effective in women with estrogen receptor (ER)-positive breast cancer, according to a study published March 13 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine.
Thus, the researchers aimed to determine prospectively whether 18F-FES PET improves staging for patients with clinical stage II/III or local-regional recurrent, grade 1 or 2, ER-positive breast cancer compared with standard F-18 FDG-PET. All lesions had also been identified at mammography and MRI.
F-18 florbetaben PETscans for diagnosing Alzheimer’s disease can be reduced from 20 minutes to five minutes without losing accuracy, according to a recent study. Our findings suggest that shorter scan times are a viable and effective option for brain amyloid PET imaging in clinical settings,” the group wrote.
In a study published April 17 in ClinicalNuclearMedicine , the group at Brigham tested a new TSPO radiotracer they developed for visualizing such activity called F-18 PBR06. The researchers performed F-18 PBR06 PETscans on 22 patients with MS and eight healthy controls.
PET imaging shows different brain activity in people taking methadone or buprenorphine for opioid use disorder (OUD), according to a presentation at the recent Society of NuclearMedicine and Molecular Imaging annual meeting. They tracked serum levels of methadone or buprenorphine for the OUD subjects.
FAPI-PET imaging could emerge as a new tool for assessing patients with single pulmonary tumors, especially in those with negative results on other scans, according to a study published April 11 in the Journal of NuclearMedicine. Image courtesy of the Journal of NuclearMedicine. “In
Patients with less tau pathology on PETscans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Research suggests that the accumulation of these proteins is a continuous process that starts decades before the onset of symptoms.
A group in France has offered an explanation for long COVID brain fog, with the concept based on a visual brain pattern they discovered on patient PETscans, according to a study published October 13 in Medical Hypotheses. “We A) PETscan of a healthy subject. (B) B) PETscan of a long COVID patient.
Dynamic PETscans acquired in half the time of normal scans appear clinically feasible for patients with lung lesions, according to nuclearmedicine researchers in Shenzhen, China. A 60-year-old male patient with clinical suspicion of lung cancer. The article was published March 5 in EJNMMI Physics.
Clinical brain imaging with a newly developed portable PET scanner appears feasible, with a comparison to conventional PET imaging for the first time revealing similar results in human subjects, according to a group in New York City. The study was published on December 14 in the Journal of NuclearMedicine.
The findings were published in ClinicalNuclearMedicine. The newly published study involved performing PETscans on 22 people with MS and eight healthy controls. Those being treated with low-efficacy treatments had more abnormalities on their PETscans, suggesting more microglial cell activation.
Gallium-68 (Ga-68) fibroblast activation protein inhibitor (FAPI) PET/CT is a promising new method for imaging gastric cancer, according to a study published January 16 in the Journal of Cancer Research and Clinical Oncology. International) and courtesy of the Journal of Cancer Research and Clinical Oncology.
tesla MRI AI body composition analysis Cardiac PET Cryo/thermoablation CT colonography Genicular artery embolization Hyperpolarized xenon-129 MRI PET/MRI Photon-counting CT Radiomics Theranostics Whole-body MRI screening Image of the Year 3D PET/MR image. PETscans predict patient response to Pluvicto.
An international survey of treatment centers has revealed significant differences in several aspects of Lu-177 PSMA-617 prostate cancer therapy, including patient imaging protocols, according to a study published January 18 in the Journal of NuclearMedicine. In addition, different PET radiotracers are used.
30, 2025 Earlier this month, the Society of NuclearMedicine and Molecular Imaging (SNMMI) and the Alzheimers Association released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Thu, 01/30/2025 - 10:20 Jan.30,
milla1cf Fri, 02/09/2024 - 09:17 February 9, 2024 — A novel PET imaging technique can noninvasively detect active inflammation in the body before clinical symptoms arise, according to research published in the February issue of The Journal of NuclearMedicine.
Reimbursement barriers Unfortunately, until recently, there were significant barriers to receiving amyloid PET imaging in some regions. Centers for Medicare and Medicaid Services (CMS), for example, did not cover amyloid PETscans outside of clinical trials for Medicare beneficiaries and only covered one scan per patient’s lifetime.
mtaschetta-millane Sat, 06/24/2023 - 15:00 June 24, 2023 — A newly developed technology called “augmented whole-body scanning via magnifying PET” ( AWSM-PET ) has been shown to enhance the image resolution and system sensitivity of clinical whole-body PET/CT imaging.
Flavio Forrer , MD, PhD, Chairman of NuclearMedicine in the Division of Radiology and NuclearMedicine at Kantonsspital St. CR and CNR demonstrated using clinical data with inserted lesions of known size, location, and contrast. Gallen in Switzerland [vii]. iv] Omni Legend 32 cm has up to 2.2
The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use. Fruhwirth, G. Kneilling, M., De Vries, I. Weigelin, B.,
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. The nuclear radiologist, nuclearmedicine technologist, and radiation safety team are all present to administer an infusion.
Positron Emission Tomography Imaging has advanced with cutting-edge technologies, enhancing diagnostic accuracy and expanding clinical applications dramatically. The post Breakthroughs in Positron Emission Tomography Imaging appeared first on Open MedScience.
Food and Drug Administration's (FDA) approvals of radiopharmaceuticals for neuroendocrine tumors and then for prostate cancer, theranostics has picked up momentum in clinical practice, propelled by encouraging research. The nuclear radiologist, nuclearmedicine technologist, and radiation safety team are all present to administer an infusion.
Several presenters at the Society for NuclearMedicine and Molecular Imaging's (SNMMI) 2024 meeting in Toronto shared new findings in women's studies. Gayton oversees clinical operations at Precirix and serves as the company's chief development officer. Women's theranostics appears to already be on the horizon.
In small studies, F-18 PSMA-1007 PET/CT has shown promise as a more accurate approach based on its ability to reveal prostate-specific membrane antigen (PSMA) on the surface of cancer cells. In this phase II clinical trial, the researchers sought to evaluate the approach further.
mtaschetta-millane Sat, 06/24/2023 - 17:00 June 24, 2023 — A new ultra-high resolution (UHR) brain PET scanner may have the ability to characterize previously indistinguishable brain regions that are known to be involved in Alzheimer’s disease , depressive disorders, visual attention disorders, tinnitus, and other conditions.
This standard has revolutionized the radiology industry, encompassing many imaging modalities such as X-rays, computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, nuclearmedicine, PETscans, etc. For example, a single CT scan can be over 30 MB.
It's only been a few years since a dedicated track in nuclearmedicine and molecular imaging was established at the meeting, and the practice already dominates it. AI studies in nuclearmedicine appear to be picking up steam as well. The system detected significantly more amyloid plaque than conventional PETscans.
8, 2025 The Society of NuclearMedicine and Molecular Imaging (SNMMI) and the Alzheimers Association have released updated appropriate use criteria (AUC) for amyloid and tau PET imaging in patients with mild cognitive impairment, Alzheimers disease and other dementias. tim.hodson Tue, 01/14/2025 - 16:48 Jan.8,
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content